Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdel-Majid Khatib

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitorsRachid Lahlil, Fabien Calvo, Abdel-Majid Khatib
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Knock-out mouse models of proprotein convertases: unique functions or redundancy?John W M Creemers, Abdel-Majid Khatib
Scientific Reports|February 15, 2024
Apela promotes blood vessel regeneration and remodeling in zebrafishNicolas Nys, Abdel-Majid Khatib, Geraldine Siegfried
Frontiers in Immunology|May 2, 2022
The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and RepressionSimon Pernot, Serge Evrard, Abdel-Majid Khatib
Biological Chemistry|August 18, 2006
The proprotein convertases and their implication in sterol and/or lipid metabolismNabil G Seidah, Abdel Majid Khatib, Annik Prat
Cancers|September 23, 2020
Loss of Proprotein Convertase Furin in Mammary Gland Impairs proIGF1R and proIR Processing and Suppresses Tumorigenesis in Triple Negative Breast CancerZongsheng He, Abdel-Majid Khatib, John W M Creemers
Oncogene|January 8, 2022
The proprotein convertase furin in cancer: more than an oncogeneZongsheng He, Abdel-Majid Khatib, John W M Creemers
Cancer Letters|May 12, 2020
Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancerZongsheng He, Abdel-Majid Khatib, John W M Creemers
Medicinal Research Reviews|October 5, 2006
Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertasesYannick Bontemps, Nathalie Scamuffa, Fabien Calvo, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 2, 2011
Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cellsNathalie Scamuffa, Peter Metrakos, Fabien Calvo, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitorsRachid Lahlil, Fabien Calvo, Abdel-Majid Khatib
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Knock-out mouse models of proprotein convertases: unique functions or redundancy?John W M Creemers, Abdel-Majid Khatib
Scientific Reports|February 15, 2024
Apela promotes blood vessel regeneration and remodeling in zebrafishNicolas Nys, Abdel-Majid Khatib, Geraldine Siegfried
Frontiers in Immunology|May 2, 2022
The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and RepressionSimon Pernot, Serge Evrard, Abdel-Majid Khatib
Biological Chemistry|August 18, 2006
The proprotein convertases and their implication in sterol and/or lipid metabolismNabil G Seidah, Abdel Majid Khatib, Annik Prat
Cancers|September 23, 2020
Loss of Proprotein Convertase Furin in Mammary Gland Impairs proIGF1R and proIR Processing and Suppresses Tumorigenesis in Triple Negative Breast CancerZongsheng He, Abdel-Majid Khatib, John W M Creemers
Oncogene|January 8, 2022
The proprotein convertase furin in cancer: more than an oncogeneZongsheng He, Abdel-Majid Khatib, John W M Creemers
Cancer Letters|May 12, 2020
Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancerZongsheng He, Abdel-Majid Khatib, John W M Creemers
Medicinal Research Reviews|October 5, 2006
Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertasesYannick Bontemps, Nathalie Scamuffa, Fabien Calvo, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 2, 2011
Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cellsNathalie Scamuffa, Peter Metrakos, Fabien Calvo, et al.
Pageof 8